Literature DB >> 10087069

Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.

J D Cooper1, A Messer, A K Feng, J Chua-Couzens, W C Mobley.   

Abstract

The neuronal ceroid lipofuscinoses (NCL) are progressive neurodegenerative disorders with onset from infancy to adulthood that are manifested by blindness, seizures, and dementia. In NCL, lysosomes accumulate autofluorescent proteolipid in the brain and other tissues. The mnd/mnd mutant mouse was first characterized as exhibiting adult-onset upper and lower motor neuron degeneration, but closer examination revealed early, widespread pathology similar to that seen in NCL. We used the autofluorescent properties of accumulated storage material to map which CNS neuronal populations in the mnd/mnd mouse show NCL-like pathological changes. Pronounced, early accumulation of autofluorescent lipopigment was found in subpopulations of GABAergic neurons, including interneurons in the cortex and hippocampus. Staining for phenotypic markers normally present in these neurons revealed progressive loss of staining in the cortex and hippocampus of mnd/mnd mice, with pronounced hypertrophy of remaining detectable interneurons. In contrast, even in aged mutant mice, many hippocampal interneurons retained staining for glutamic acid decarboxylase. Treatment with insulin-like growth factor-1 partially restored interneuronal number and reduced hypertrophy in some subregions. These results provide the first evidence for the involvement of interneurons in a mouse model of NCL. Moreover, our findings suggest that at least some populations of these neurons persist in a growth factor-responsive state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087069      PMCID: PMC6786069     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Estimation of nuclear population from microtome sections.

Authors:  M ABERCROMBIE
Journal:  Anat Rec       Date:  1946-02

Review 2.  Morphologic diagnosis in neuronal ceroid lipofuscinosis.

Authors:  H H Goebel
Journal:  Neuropediatrics       Date:  1997-02       Impact factor: 1.947

Review 3.  Metabolism and nervous system disease: a challenge for our times. Part II.

Authors:  E Roberts
Journal:  Metab Brain Dis       Date:  1986-06       Impact factor: 3.584

4.  Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies.

Authors:  M Haltia; J Rapola; P Santavuori; A Keränen
Journal:  J Neurol Sci       Date:  1973-03       Impact factor: 3.181

5.  Retinal degeneration in motor neuron degeneration (mnd) mutant mice.

Authors:  A Messer; J Plummer; V Wong; M M Lavail
Journal:  Exp Eye Res       Date:  1993-11       Impact factor: 3.467

Review 6.  The endosomal-lysosomal system of neurons: new roles.

Authors:  R A Nixon; A M Cataldo
Journal:  Trends Neurosci       Date:  1995-11       Impact factor: 13.837

7.  Unbiased stereological estimation of the number of neurons in the human hippocampus.

Authors:  M J West; H J Gundersen
Journal:  J Comp Neurol       Date:  1990-06-01       Impact factor: 3.215

8.  A yeast model for the study of Batten disease.

Authors:  D A Pearce; F Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Growth factor-induced neurite growth in primary neuronal cultures of dogs with neuronal ceroid lipofuscinosis.

Authors:  W A Dunn; M K Raizada; E S Vogt; E A Brown
Journal:  Int J Dev Neurosci       Date:  1994-06       Impact factor: 2.457

10.  Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis).

Authors:  N A Hall; B D Lake; N N Dewji; A D Patrick
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

View more
  22 in total

1.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

2.  Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Catherine Kielar; Lucy Maddox; Ellen Bible; Charlie C Pontikis; Shannon L Macauley; Megan A Griffey; Michael Wong; Mark S Sands; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2006-10-12       Impact factor: 5.996

3.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

4.  Lipofuscin accumulation and gene expression in different tissues of mnd mice.

Authors:  Giovanna Traina; Paolo Bigini; Giuseppe Federighi; Leopoldo Sitia; Gabriela Paroni; Fabio Fiordaliso; Monica Salio; Caterina Bendotti; Marcello Brunelli
Journal:  Mol Neurobiol       Date:  2012-03-08       Impact factor: 5.590

5.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.

Authors:  J D Cooper; A Salehi; J D Delcroix; C L Howe; P V Belichenko; J Chua-Couzens; J F Kilbridge; E J Carlson; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.

Authors:  Reza M Salek; Michael R Pears; Jonathan D Cooper; Hannah M Mitchison; David A Pearce; Russell J Mortishire-Smith; Julian L Griffin
Journal:  J Biomol NMR       Date:  2011-04-03       Impact factor: 2.835

7.  Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.

Authors:  Kristina Oresic; Britta Mueller; Domenico Tortorella
Journal:  Biosci Rep       Date:  2009-06       Impact factor: 3.840

8.  Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL.

Authors:  Carina von Schantz; Catherine Kielar; Stine N Hansen; Charlie C Pontikis; Noreen A Alexander; Outi Kopra; Anu Jalanko; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

Review 9.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis.

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Karen J Barwell; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2008-06-25       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.